APR 27, 2020 9:46 AM PDT

The Tumor Suppressor and its Regulator: An Indirect Oncogene

WRITTEN BY: Jasper Cantrell

Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the direct nature of their cancer-promoting actions. This sometimes resulted in leaving behind good, but less obvious, options behind.  For example, phosphatase and tensin homolog (PTEN) is a known tumor suppressor with no direct oncogene connected with it. However, there is an observable decrease in PTEN levels when you look at several cancers.  A group out of Shanghai decided to investigate this correlation.

The testing began by confirming previous research that determined the location of PTEN in the cell. PTEN is present in both the cytoplasm and nucleus. In the cytoplasm, it is responsible for the de-phosphorylation of critical proteins that suppress tumor progress. In the nucleus, PTEN regulates the expression genes through several epigenetic activities. Nuclear localized PTEN is where this group focused, as exploratory experiments showed proteasome-dependent degradation of nuclear PTEN, but oddly not cytoplasmic PTEN.

Conducting a brief screen to determine how nuclear PTEN is degraded, and it was confirmed to be proteasome-dependent. Another team had found that the ubiquitylation of PTEN prevented its accumulation in the nucleus. Ubiquitylation is the modification of a protein that targets the protein for destruction by the proteasome. To identify which protein is responsible for the ubiquitylation of PTEN, the conducted an immune-precipitation screen. F-box only protein 22 (FBXO22) was the only ubiquitin ligase that interacted with PTEN. Further study showed it to localized to the nucleus, and interacted with PTEN, making it the next target for investigation.

A series of experiments were designed to examine the connection between PTEN and FXBO22. A complete knockout of FBOX22 lead to an accumulation of nuclear PTEN but did not affect cytoplasmic PTEN. By synthetically increasing the expression of FBXO22, they saw a decrease in nuclear PTEN levels. In vitro experiments determined the ubiquitylation site on PTEN to be at lysine221 (K221), which, when mutated, completely hindered FBXO22 dependent nuclear PTEN degradation. The team then conducted experiments on colorectal tumor cell lines with FBXO22 and either wild type PTEN, the PTEN K221R, and controls and confirmed that PTEN tumor suppression was depleted upon FBXO22s tagging of nuclear PTEN.

A final examination of data from The Cancer Genome Atlas and The Expression Omnibus showed that FBXO22 is upregulated in a subset of cancers.  The group concludes, “Our study reveals that nuclear and cytoplasmic PTEN not only exert distinct functions, but are also subjected to distinct regulatory mechanisms, and reports the first mechanism that preferentially regulates the stability of nuclear but not cytoplasmic PTEN.”  Targeting indirect oncogenic mechanisms such as this can be troublesome for researchers, but never-the-less they are avenues for exploration. After all, not every solution is straightforward.

Sources: Nature, European Society for Medical Oncology
 

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
DEC 07, 2020
Cancer
Black women with breast cancer have higher rates of mortality and comorbidities
DEC 07, 2020
Black women with breast cancer have higher rates of mortality and comorbidities
New research published today the American Cancer Society’s peer-reviewed journal, Cancer, looks at the mortality r ...
DEC 20, 2020
Cell & Molecular Biology
Chromatin Doesn't Behave Like a Liquid or Solid - It's a Gel
DEC 20, 2020
Chromatin Doesn't Behave Like a Liquid or Solid - It's a Gel
A cell's nucleus has to hold the entire genome. To do that, the DNA has to be carefully arranged and compacted by protei ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
Loading Comments...